This same ligand‒receptor interaction also resulted in significant upregulation of MIF in malignant T cells and interactions of malignant T cells expressing MIF with macrophages and B cells expressing CD74 in CTCL [131]. Here, MIF is linked to primary cutaneous T-cell non-Hodgkin lymphoma.